ASAHI KASEI PHARMA

Contact us

AsahiKASEI

Policy on Disclosure of Clinical Trial Information

Asahi Kasei Pharma Corporation is taking initiatives to improve the transparency of the clinical trials it conducts, in accordance with principles for ensuring transparency including IFPMA Principles for Responsible Clinical Trial Data Sharing. We are contributing to advancement of science and improvement of public health by disclosing clinical trial information and information such as results and clinical trial data in a timely and appropriate manner.

Disclosure of Clinical Trial Information

Asahi Kasei Pharma Corporation releases information about its ongoing and past clinical trials via a clinical trial information registration website that is accessible to the general public. The information available includes summaries of clinical trial plans and progress updates.

Please visit the following website for clinical trial information and summaries of clinical trial results.

  • This is a public website operated by the National Institute of Public Health where you can search for information on clinical trials and clinical research conducted in Japan in general. The information is published in Japanese.
  • This is a public website operated by the National Library of Medicine, National Institutes of Health (NIH), where you can search for information on clinical trials and clinical research conducted around the world in general. The information is published in English.
  • This is a public website operated by the European Medicines Agency (EMA) where you can search for information on clinical trials and clinical research conducted in the European Union (EU) or European Economic Area (EEA) in general. The information is published in English.